Unveiling tumor senescence-driven prognostic heterogeneity via MALISS in stage II/III colorectal cancer
MALISS serves as a robust tool for risk stratification and provides valuable insights into tumor biology, offering a promising approach to address prognostic heterogeneity in stage II/III CRC.
Authors
- Xiangyun Niu (ORCID: https://orcid.org/0000-0002-0092-0080)
- Xinyu Liu (ORCID: https://orcid.org/0000-0001-8001-1866)
- Wei Chong (ORCID: https://orcid.org/0000-0002-1074-8595)
- B. Liu
- Yaodong Sang (ORCID: https://orcid.org/0009-0003-3277-7201)
- Yuhao Tong (ORCID: https://orcid.org/0009-0009-6186-9926)
- Lei Li (ORCID: https://orcid.org/0000-0001-8723-3461)
- Xingyu Zhu (ORCID: https://orcid.org/0009-0001-8392-369X)
- Kang Xu
- Feng Gao
- Hao Chen
- Youyong Tang
Institutions
- Weifang Medical University (CN)
- Shandong Provincial Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-06
- DOI
- https://doi.org/10.3389/fimmu.2025.1744719
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00